Article
The Genetic and Clinical Significance of Fetal Hemoglobin Expression in Sickle Cell Disease.
Medical principles and practice : international journal of the Kuwait University, Health Science Centre - 1 Jan 2021
Adekile Adekunle
Abstract excerpt
Sickle cell disease (SCD) is phenotypically heterogeneous. One major genetic modifying factor is the patient's fetal hemoglobin (HbF) level. The latter is determined by the patient's β-globin gene cluster haplotype and cis- and trans-acting single nucleotide polymorphisms (SNPs) at other distant quantitative trait loci (QTL). The Arab/India haplotype is associated with persistently high HbF levels and also a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
